Tapping away fear: simple technique may ease movement problems after obesity surgery
NCT ID NCT06780371
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether Emotional Freedom Technique (EFT), a therapy that involves tapping on specific body points, could reduce kinesiophobia (fear of movement) and pressure sore risk in 148 adults who had obesity surgery. Participants received EFT sessions, and researchers measured changes in their fear levels and skin risk scores. The goal was to see if this gentle, non-drug approach could help patients recover more comfortably.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Emotional Freedom Technique (tapping therapy)
- What this could lead to
- If it works, this could offer a simple, drug-free way to help patients move more comfortably after obesity surgery and lower their risk of bedsores.
- What could go wrong
- This is a small, completed study without a control group, so results may not be reliable or apply to everyone. The technique is unproven and effects may be due to placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BARIATRIC SURGERY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bitlis Eren University
Bitlis, 13100, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Can a new drug boost Semaglutide's power against diabetes and obesity?
- Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
- A daily pill for obesity? zenagamtide faces its biggest test yet.
- Dance and walking may boost heart health in obesity — a trial puts it to the test